3,3"-Dihydroxybenzidine

Hazard statements (CLP)

H315, H319, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Warning

Hazard statements

H315 Causes skin irritation. H319 Causes serious eye irritation. H351 Suspected of causing cancer. H373 May cause damage to organs (Liver) through prolonged or repeated exposure.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ atten- tion. P337 + P313 If eye irritation persists: Get medical advice/ atten-

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - repeated expo- H373: May cause damage to organs through prolonged sure, Category 2, Liver or repeated exposure.